Akston Biosciences
Rassol Laleau has 8 years of professional experience in the field of bioanalytics and pharmacokinetics. Rassol began their career in 2008 as a Research Associate at SmartCells, Inc. In 2011, they joined ImmunoGen, Inc. as a Research Associate III, where they were promoted to Senior Research Associate and then Resident Pharmacokinetics Modeler. In 2019, they moved to Akston Biosciences Corporation as a Quantitative Bioanalytics Scientist.
Rassol Laleau completed a Master of Science in Biomedical Engineering and Biotechnology from the University of Massachusetts Lowell in 2018. Prior to that, they earned a BS in Biological and Biomedical Sciences from Andrews University.
Akston Biosciences
Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics, including vaccines, ultra-long-acting insulins, and autoimmune disease therapies.